The Lone Star State ranks 19th in the U.S. for its teaching environment. Educational First Steps/Facebook

If Texas were a student, it would earn a mediocre grade when it comes to the state's atmosphere for schoolteachers. In a new study from personal finance website WalletHub, Texas ranks 19th for its teaching environment compared with the 49 other states and the District of Columbia.

While Texas earns good marks for teacher salaries, the rest of the state's grades for teachers are below average, according to WalletHub. In all, WalletHub studied 22 metrics to come up with its report card.

Texas ranks second for the average starting salary for teachers and 13th for the average salary for teachers. However, both data points adjusted for cost of living in Texas. The state also ranked 13th for the 10-year change in teachers' salaries, WalletHub says. Texas doesn't fare nearly as well in WalletHub's other measurements, though:

  • No. 29 for pupil-teacher ratio.
  • No. 30 for teacher safety.
  • No. 32 for fewest teachers per student projected for 2026.
  • No. 36 for school quality.
  • No. 36 for per-student spending in public schools. According to the National Education Association (NEA), per-student funding in Texas is $2,300 less than the national average.
  • No. 37 for teachers' potential for income growth.

A recent survey by the Texas State Teachers Association backs up the notion that the state's teachers aren't in the same class as their counterparts in places like New York, Connecticut, Minnesota, and Illinois, which were graded by WalletHub as the best states for teachers.

For instance, the Texas survey indicates that about four of every 10 teachers expect to take jobs outside the classroom to make ends meet during the academic year. In addition, the typical teacher in the survey reported spending an average of $738 a year on school supplies out of his or her own pocket.

According to the survey, moonlighting teachers in Texas average 14.1 hours a week at their extra jobs. That's on top of the 17 hours a week they spend outside the classroom on school-related work.

The Austin-based Texas State Teachers Association, an affiliate of the NEA, says the average salary of teachers in the survey was $53,221, which is $7,300 below the national average. According to the NEA, Texas ranks 29th for teacher pay.

Noel Candelaria, president of the Texas association, pins the blame for the plight of Texas teachers on Gov. Greg Abbott, Lt. Gov. Dan Patrick, and their legislative allies. He says they've failed to properly finance public education.

"Our teachers … remain dedicated to their students' success, even if it means spending evenings and weekends at extra jobs away from their families," Candelaria says in a release. "It's time for our elected officials at the state Capitol to demonstrate the same kind of dedication to our children by providing the necessary resources."

In August, Abbott said he wants to boost pay for the state's best teachers, putting them on a path toward earning more than $100,000 a year — without a hike in property taxes.

"Teaching is a calling; it would be hard to do otherwise," Abbott said. "But I want to ensure that teaching in Texas also becomes a profession, where we are able to attract the very best and keep the very best."

"We can and we must do more to improve education in Texas," the governor said. "As we approach this next legislative session [in 2019], one of my top goals is to improve education by investing more in our teachers and students."

---

This story originally appeared on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”